Gout, Allopurinol Use, and Heart Failure Outcomes
2010; American Medical Association; Volume: 170; Issue: 15 Linguagem: Inglês
10.1001/archinternmed.2010.198
ISSN1538-3679
Autores Tópico(s)Liver Disease and Transplantation
ResumoBackground: Hyperuricemia is associated with reduced survival among patients with heart failure (HF), but the effect of gout on HF outcomes is unknown.A recent randomized trial suggested that allopurinol may reduce adverse outcomes among patients with hyperuricemia and HF.Our objective was to determine whether gout and allopurinol use are associated with HF outcomes.Methods: Time-matched, nested case-control analysis of a retrospective cohort of patients with HF who were 66 years or older using health care databases in Quebec, Canada.The primary outcome measure was a composite measure of HF readmission and all-cause mortality.The secondary outcome measure was all-cause mortality.Rate ratios were calculated using conditional logistic regression and adjusted for known prognostic factors.Results: Of the 25 090 patients in this cohort, 14 327 experienced the primary outcome.Both a remote his-
Referência(s)